3月31日金融一线消息，民生银行今日召开2025年度业绩交流会。对于净息差相关问题，副行长、董事 会秘书李彬指出，2025年民生银行净息差同比提升了1个BP，呈现了企稳改善的态势。她从以下几个方 面分析： 3月31日金融一线消息，民生银行今日召开2025年度业绩交流会。对于净息差相关问题，副行长、董事 会秘书李彬指出，2025年民生银行净息差同比提升了1个BP，呈现了企稳改善的态势。她从以下几个方 面分析： 一是存款结构更加优化。在近几年战略落地的过程中，民生银行始终以客户为中心，持续完善产品与服 务，以代发收单、财富管理等重点业务为抓手，有效带动了活期存款占比的提升。同时，也主动加强了 中长期存款管理，不断优化存款期限结构，全年存款付息率下降了40个BP。 二是精细化管理同业资金成本。一方面加强同业客户的综合化经营，拓宽同业资金来源；另一方面根据 流动性情况前瞻性分析市场，灵活把控资金吸收节奏，做好期限和产品的结构摆布。全年同业资金成本 下降明显。 一是存款结构更加优化。在近几年战略落地的过程中，民生银行始终以客户为中心，持续完善产品与服 务，以代发收单、财富管理等重点业务为抓手，有效带动了活期存款占比的提 ...

黄红日表示，一方面，政策在持续发力，市场在逐步修复，这将为我行资产质量的稳定提供有力支撑； 另一方面，存量风险的化解、部分企业经营的调整、区域和项目的分化仍将带来一定比例的不良的产 生。 黄红日表示，一方面，政策在持续发力，市场在逐步修复，这将为我行资产质量的稳定提供有力支撑； 另一方面，存量风险的化解、部分企业经营的调整、区域和项目的分化仍将带来一定比例的不良的产 生。 下一阶段，黄红日指出，民生银行将继续执行总量控制、盘活存量、优化增量的总体策略，积极落实监 管要求，加快推进存量风险的化解，适度有序的发展增量业务，保持房地产业务平稳健康的发展。 责任编辑：潘翘楚 3月31日金融一线消息，民生银行今日召开2025年度业绩交流会。谈及房地产资产质量的展望，该行副 行长黄红日表示："我们判断，短期内仍存压力，但长期趋于平稳。" 下一阶段，黄红日指出，民生银行将继续执行总量控制、盘活存量、优化增量的总体策略，积极落实监 管要求，加快推进存量风险的化解，适度有序的发展增量业务，保持房地产业务平稳健康的发展。 责任编辑：潘翘楚 3月31日金融一线消息，民生银行今日召开2025年度业绩交流会。谈及房地产资产质量的展望， ...

热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易 客户端 华润万象生活（01209）盘中涨超7%，截至发稿，股价上涨6.16%，现报46.88港元，成交额1.23亿港 元。 行情图 热点栏目 自选股 数据中心 行情中心 资金流向 模拟交易 客户端 华润万象生活（01209）盘中涨超7%，截至发稿，股价上涨6.16%，现报46.88港元，成交额1.23亿港 元。 华润万象生活发布2025年度业绩，收益180.22亿元（人民币，下同），同比增加5.06%；权益股东应占 溢利39.69亿元，同比增加10.31%；核心净利润增长13.7%至39.5亿元。董事会决议宣派末期股息每股 0.509元，同时宣派末期特别股息每股0.341 元，全年每股股息同比增长12.7%至1.731元，连续三年实现 核心净利润 100%分派。 责任编辑：卢昱君 行情图 华润万象生活发布2025年度业绩，收益180.22亿元（人民币，下同），同比增加5.06%；权益股东应占 溢利39.69亿元，同比增加10.31%；核心净利润增长13.7%至39.5亿元。董事会决议宣派末期股息每股 0.509元，同时宣派末期特别股息每股0.341 元 ...

高迎欣表示："我们打造'一个民生'，从总行、分行，到各个分行之间，分行和附属机构之间，国内分 行和海外分行之间，我行建立了符合现代银行服务客户需求的一种模式。我们要在考核体制上、资源分 配上进行重塑，因此，我行能够在客户方面体现出全行各条线之间、总分行之间是一个整体。" 责任编辑：潘翘楚 责任编辑：潘翘楚 3月31日金融一线消息，民生银行今日召开2025年度业绩交流会。该行董事长高迎欣在会上表示，我行 在营销模式、经营理念、组织架构、组织体系、人事管理，特别是员工的成长路径，以及整个组织效能 等方面，做了大量的、细致的改变，同时，我行的文化建设也取得了非常大的成效，而以上成效最终要 落在银行能不能从产品服务、营销模式上，从而体现出我行本身的特色。 3月31日金融一线消息，民生银行今日召开2025年度业绩交流会。该行董事长高迎欣在会上表示，我行 在营销模式、经营理念、组织架构、组织体系、人事管理，特别是员工的成长路径，以及整个组织效能 等方面，做了大量的、细致的改变，同时，我行的文化建设也取得了非常大的成效，而以上成效最终要 落在银行能不能从产品服务、营销模式上，从而体现出我行本身的特色。 高迎欣表示："我们打 ...

Core Viewpoint - The chairman of Minsheng Bank, Gao Yingxin, emphasized the importance of risk management and internal control during the 2025 performance exchange meeting, stating that these aspects take precedence over business opportunities [1][1]. Group 1: Risk Management - Minsheng Bank has prioritized risk management and internal control in recent years, placing them at the forefront of its operations [1][1]. - The bank will not pursue any business opportunities if there are doubts regarding risk management, internal control, or regulatory compliance, even if such opportunities could generate revenue [1][1].

Core Viewpoint - The report indicates that China Merchants Bank is expected to achieve a revenue growth of 0.01% and a net profit attributable to shareholders growth of 1.2% in 2025, with a target price set at 55.8 yuan and a maintainance of the "buy" rating [1][2]. Group 1: Financial Performance - In 2025, the bank's revenue and net profit attributable to shareholders are projected to grow by 0.01% and 1.2% year-on-year, with growth rates improving by 0.5 percentage points and 0.7 percentage points compared to the first three quarters [2]. - For Q4 2025, the bank's revenue and net profit are expected to increase by 1.6% and 3.4% year-on-year, with quarter-on-quarter growth rates of -0.5 percentage points and +2.4 percentage points respectively [2]. - The net interest margin for 2025 is projected at 1.87%, remaining stable compared to the previous three quarters, with a slight improvement in Q4 to 1.86% [3]. Group 2: Income Sources - The bank's non-interest income is expected to grow by 4.4% year-on-year in 2025, with a significant increase of 16.3% in Q4 compared to the same quarter last year [3]. - Wealth management income is projected to reach 26.7 billion yuan in 2025, reflecting a year-on-year growth of 21.4%, driven by substantial increases in sales of financial products [3]. Group 3: Asset Quality - The overall asset quality remains stable, with a non-performing loan ratio of 0.94% and a provision coverage ratio of 392% at the end of 2025, showing no change from Q3 [4]. - The overdue loan ratio improved to 1.25% by the end of 2025, down 9 basis points from Q3 [4]. - The bank's retail overdue rate is reported at 1.71%, with a notable decline in overdue rates for consumer loans and credit cards [4].

Core Viewpoint - Fosun International reported a significant loss of approximately RMB 23.4 billion for the fiscal year 2025, attributed mainly to non-cash impairment charges rather than a deterioration in operational fundamentals [1][2] Financial Performance - For the year ending December 31, 2025, Fosun's total revenue reached RMB 173.4 billion, a decline of 9.74% year-on-year [1] - The net profit attributable to shareholders plummeted by 437.97% to RMB 23.396 billion [1] Strategic Focus - The company is implementing a "streamlining and focusing on core business" strategy, with asset impairment charges being described as "roof repairs on a sunny day" to better allocate resources towards high-growth sectors [2] - Real estate-related impairments accounted for approximately 55% of the total, while non-core asset impairments made up about 45% [2] Core Business Growth - The four core enterprises—Fosun Pharma, Yuyuan, Fosun Portugal Insurance, and Fosun Tourism—generated total revenues of RMB 128.2 billion, representing 74% of the group's total revenue, an increase of 3% year-on-year [2] - Fosun Pharma's innovative drug revenue reached RMB 9.893 billion, a year-on-year increase of 29.59%, contributing to 33.16% of the pharmaceutical business revenue [3] Insurance Sector Performance - Fosun's insurance businesses showed comprehensive growth, with Fosun Portugal Insurance achieving gross premiums of EUR 6.53 billion and a net profit of EUR 201 million, up 15.8% [3] - Domestic insurance companies, including Fosun Baodexin Life, reported a scale premium of RMB 13.28 billion, a 41.6% increase, and a net profit of RMB 650 million, growing by 492% [3] Consumer and Tourism Developments - Yuyuan's restaurant brand Songhe Lou opened its first overseas store in London, while the jewelry brand Laomiao launched its first overseas store in Kuala Lumpur [4] - Club Med achieved record revenue of RMB 17.97 billion, a 2.1% increase, with an average global occupancy rate of 75.8%, up 1.8% [4] Future Outlook - The company aims to restore a profit scale of RMB 10 billion and reduce total liabilities to below RMB 60 billion, targeting an "investment-grade" rating [4] - Fosun is focusing on practical applications of AI to enhance efficiency rather than pursuing large model concepts [4]

Core Viewpoint - China Duty Free Group (中国中免) reported a decline in revenue and net profit for the fiscal year 2025, but showed signs of recovery in the fourth quarter, indicating potential for future growth due to strategic initiatives and market recovery [1][2]. Financial Performance - For the fiscal year 2025, the company recorded revenue of 53.694 billion yuan, a decrease of 4.92% year-on-year [1][2]. - The net profit attributable to equity shareholders was 3.644 billion yuan, down 15.73% compared to the previous year [1][2]. - In the fourth quarter of 2025, the company achieved revenue of 13.831 billion yuan, reflecting a year-on-year growth of 2.81% [1][2]. - The net profit for the fourth quarter was 534 million yuan, showing a significant increase of 53.59% year-on-year [1][2]. Market Position and Strategic Initiatives - As a leading player in the duty-free industry, the company maintains a strong core channel advantage [1][2]. - The Hainan market has demonstrated a robust recovery, contributing positively to the company's outlook [1][2]. - The acquisition of DFS's Greater China business and strategic collaboration with LVMH Group have opened new avenues for international development [1][2]. - The ongoing trend of consumer spending returning and the release of various policy benefits are expected to help the company return to a growth trajectory [1][2].

Core Viewpoint - The Australian National Bank (NAB) states that reports regarding U.S. President Donald Trump's discussions about the Iran war will only have a temporary impact on exchange rates [1][2]. Group 1: Market Impact - NAB's senior foreign exchange strategist, Rodrigo Catril, notes that there has been a slight improvement in risk appetite, leading to a decrease in the safe-haven demand for the U.S. dollar [1][2]. - Catril warns that, given the ongoing Iran conflict and the closure of the Strait of Hormuz, this trend may not be sustainable [1][2]. Group 2: Geopolitical Concerns - The reopening of the Strait of Hormuz is deemed crucial, as it would restore shipping traffic in the Middle East to pre-conflict levels [1][2]. - NAB expresses uncertainty about how a U.S. withdrawal could resolve the ongoing issues, indicating that the absence of shipping through the Strait of Hormuz could lead to persistently high oil prices for both the U.S. and the rest of the world [1][2].

Group 1 - CXO leading companies reported better-than-expected annual results, with Zhaoyan New Drug achieving a net profit of nearly 300 million yuan in 2025, a year-on-year increase of 300% [1][4] - Kailaiying reported revenue and net profit growth, with a net profit of 1.132 billion yuan, representing a year-on-year increase of 19.35% [1][4] - The AH medical sector saw a rise, with medical ETFs (512170) and Hong Kong Stock Connect medical ETF Huabao (159137) both increasing over 2% at one point, and A-shares hitting the limit up [1][4] Group 2 - The CXO content in medical ETFs (512170) and Hong Kong Stock Connect medical ETF Huabao (159137) is 25% and 42%, respectively [2][5] - The Zhejiang Merchants Pharmaceutical team analyzed that the CXO industry is undergoing a clearing process, and they are optimistic about domestic leading CDMO companies and CRO companies benefiting from the recovery of domestic demand [2][5] - The analysis indicates that the fundamental turning point for CXO has appeared and is expected to continue to recover [2][5]